Dados Bibliográficos

AUTOR(ES) H. Ward , S. Day , R Charles Coombes , Louise McGrath‐Lone , Claudia Schoenborn
AFILIAÇÃO(ÕES) Patient Experience Research Centre School of Public Health Imperial College London UK, Department of Medical Oncology Imperial College London London UK
ANO 2017
TIPO Artigo
PERIÓDICO Sociology of Health and Illness
ISSN 0141-9889
E-ISSN 1467-9566
EDITORA Sage Publications (United States)
DOI 10.1111/1467-9566.12457
CITAÇÕES 8
ADICIONADO EM 2025-08-18
MD5 e3fca35d21f4e47eefd51c02e38f2ceb

Resumo

We conducted ethnographic research in collaboration with a large, research‐intensive London breast cancer service in 2013–2014 so as to understand the practices and potential effects of stratified medicine. Stratified medicine is often seen as a synonym for both personalised and precision medicine but these three terms, we found, also related to distinct facets of treatment and care. Personalised medicine is the term adopted for the developing 2016NHSEngland Strategy, in which breast cancer care is considered a prime example of improved biological precision and better patient outcomes. We asked how this biologically stratified medicine affected wider relations of care and treatment. We interviewed formally 33 patients and 23 of their carers, including healthcare workers; attended meetings associated with service improvements, medical decision‐making, public engagement, and scientific developments as well as following patients through waiting rooms, clinical consultations and other settings. We found that the translation of new protocols based on biological research introduced further complications into an already‐complex patient pathway. Combinations of new and historic forms of stratification had an impact on almost all patients, carers and staff, resulting in care that often felt less rather than more personal.

Ferramentas